1.
Lisan Shidqi MI, Santosa B, Muslim M, Haitami H. Evaluation in Hematology and BCR-ABL Molecular Profiles in Patients with Chronic Myeloid Leukemia Undergoing Tyrosine Kinase Inhibitor Therapy. Med.Lab.Tech.J. [Internet]. 2022Dec.19 [cited 2025Jul.22];8(2):200-8. Available from: https://www.ejurnal-analiskesehatan.web.id/index.php/JAK/article/view/484